Applied BioCode Corp
TWSE:6598

Watchlist Manager
Applied BioCode Corp Logo
Applied BioCode Corp
TWSE:6598
Watchlist
Price: 24.05 TWD Market Closed
Market Cap: NT$2.5B

Applied BioCode Corp
Investor Relations

Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.

Show more
Loading
6598
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Winston Z. Ho Ph.D.
Founder, CEO, President & Director
No Bio Available
Mr. Jaca Liang-Kai Huang
CFO & Corporate Governance Officer
No Bio Available
Ms. Jau-Tung Pan
Accounting Supervisor
No Bio Available
Yu-Tsung Chou
Chief Information Officer
No Bio Available
Dr. Beth Laderman
Chief Scientific Officer
No Bio Available
Ms. Parisa Hanachi Ph.D.
Vice President of Marketing
No Bio Available
Mr. Jim Leigh
Vice President of Sales
No Bio Available
Julian Sanchez
Senior Director of Human Resources
No Bio Available
Ms. Ingrid Joseph
Administration Division Director
No Bio Available

Contacts

Address
TAIPEI
Taipei City
6F, No.1, Lane 28, Xingzhong Road, Neihu District
Contacts
+886287916833
www.apbiocode.com